Bayview Acquisition Corp
Bayview Acquisition Corp filed an 8-K disclosing that the Nasdaq Listing and Hearing Review Council affirmed the delisting of its securities on September 22, 2026. Trading was suspended effective July 7, 2026, after the company failed to complete its business combination with Oabay Inc. by the June 19, 2026 deadline. Nasdaq will file Form 25-NSE to formally remove the securities. The company plans to move to OTC Pink Market under tickers BAYA and BAYAR, but cautions there may be a very limited trading market.
- Nasdaq Listing Council affirmed the Panel's decision to delist Bayview's securities on September 22, 2026.
- Trading was suspended effective July 7, 2026, after the company failed to complete its Oabay business combination by June 19, 2026.
- Nasdaq will file Form 25-NSE to formally remove the company's securities from listing and registration.
- The company intends to list Ordinary Shares and Rights on OTC Pink Market under tickers BAYA and BAYAR.
- The company warns there may be a very limited trading market and no assurance of sufficient liquidity.
Price data unavailable.
A SPAC delisting from Nasdaq to OTC Pink represents a near-total loss of liquidity for public shareholders and signals the Oabay deal is effectively dead.
This is the latest in a wave of SPAC liquidations and delistings as blank-check companies that failed to close deals within their contractual windows face Nasdaq enforcement.
The company explicitly warns that trading on OTC Pink may result in a very limited market, adverse pricing, and no assurance that broker-dealers will provide quotes or that trading volume will support an efficient market.
Get filings like this before the market reacts.
Real-time SEC filing alerts, AI summaries, and a free daily digest — plus portfolio tracking that ties filings to your positions.